Now I have all the information needed. Let me produce the consolidated review.

## Summary

The paper introduces Constrained Mass Transport (CMT), a variational framework that constructs intermediate annealing-path distributions by jointly constraining both the KL divergence (trust-region) and the entropy decay between successive steps. The constraints are solved analytically (Propositions 2.1–2.3), yielding closed-form tempered-geometric densities, and the framework is instantiated with normalizing flows trained via importance-weighted forward KL. Empirically, CMT achieves competitive or state-of-the-art results on molecular Boltzmann generator benchmarks up to d=219 (the new ELIL tetrapeptide), with the ablation study cleanly demonstrating that both constraints are necessary to avoid mode collapse.

## Strengths

1. **Novel combination of trust-region and entropy constraints for sampling.** While trust-region KL bounds and entropy regularization each have priors in RL/VI, the paper's formulation of a unified constrained optimization problem (Eq. 9) that yields an analytical tempered-geometric annealing path is original for the Boltzmann sampling setting. The closed-form solutions in Propositions 2.1–2.3 make the approach theoretically transparent.

2. **Ablation study convincingly shows both constraints are necessary.** Figures 2 and 3 demonstrate that omitting the trust-region constraint causes entropy to collapse rapidly, while omitting the entropy constraint still leads to mode collapse in Ramachandran plots. Only the Geometric-tempered (both constraints) variant avoids this failure. This is the paper's strongest empirical contribution and directly supports the core claim.

3. **Strong empirical results on the largest system.** On the ELIL tetrapeptide (d=219), CMT achieves 26.06% ESS vs. 7.21% for FAB (3.61×) and 13.75% for TA-BG (1.90×), while requiring the same or fewer target evaluations. This is the highest-dimensional molecular system studied purely from energy evaluations, and the improvement over FAB is substantial.

4. **Consistent improvements across metrics and systems.** CMT achieves the best EUBO and ESS on all four benchmarks, with competitive or better RAM TV on most systems, while using comparable or fewer target evaluations. The code and ground-truth MD data are publicly released.

## Weaknesses

### Major

1. **Abstract/conclusion's "over 2.5× higher ESS" claim is overstated.** The claim is supported on the ELIL tetrapeptide vs. FAB (26.06%/7.21% = 3.61×), but the ratios vs. the strongest baselines on other systems are: 1.63× (hexapeptide vs. TA-BG), 1.04× (tetrapeptide vs. TA-BG), and 1.02× (dipeptide vs. TA-BG). The paper presents the 2.5× figure as a general achievement but it applies only in a specific comparison (ELIL vs. FAB). This is not a fatal error (the claim is not false—it is supported on one system against a SOTA baseline), but it is a misleading headline number that overstates the consistency of the gain. The paper would be stronger with a more precise claim, e.g., "up to 3.6× higher ESS."

2. **RAM TV on ELIL tetrapeptide is worse than TA-BG.** CMT achieves RAM TV 0.0313 vs. TA-BG's 0.0254 on ELIL, yet the main text says CMT "provides superior mode coverage and resolution of metastable high-energy regions (RAM TV)" across all systems. The table is transparent about this result, but the text overclaims. Moreover, this undercuts the "preserving mode diversity" narrative—CMT achieves higher ESS but captures the Ramachandran plot less faithfully than TA-BG on the largest system. A more nuanced discussion is needed.

3. **No sensitivity analysis for the central hyperparameters ε_tr and ε_ent.** The paper does not report the values used for these bounds nor study their effect across systems of different dimensionality. Since the entire method is motivated by these constraints, understanding how performance varies with ε_tr, ε_ent is essential for reproducibility and practical guidance. The paper states "Details regarding... are provided in Appendix D" and "Additional experimental results are provided in Appendix B, including... an analysis of different trust-region bounds," but the appendix was stripped by the parser. If these analyses exist in the full submission, this weakness is downgraded to Minor; if they do not, this is a significant omission.

### Minor

1. **No wall-clock time comparison.** The paper reports only target evaluations as a proxy for cost, but notes that solving the Lagrangian dual costs only 0.01% of training time (on alanine dipeptide). A wall-clock comparison would help practitioners assess the practical overhead of the dual optimization, especially on larger systems where the MC estimation of Z_{i+1} could introduce nontrivial compute.

2. **No verification that learned approximations satisfy the constraints.** The constraints (KL bound, entropy bound) are enforced on the theoretical densities q_i, not on the learned approximations \hat{q}_i. The paper provides no analysis of whether the actual D_KL(\hat{q}_{i+1} || \hat{q}_i) or H(\hat{q}_i)-H(\hat{q}_{i+1}) respect ε_tr, ε_ent. While this is standard practice in variational methods (the constraint defines the target, not the approximation), verifying these quantities would strengthen the paper.

3. **ESS/EUBO discrepancy in the ablation is undiscussed.** In Figure 2(d), the "Geometric" variant (only trust-region) attains 33.42% ESS, which is higher than CMT's 29.63%—yet the Geometric variant exhibits mode collapse in Figure 3. The paper notes this ("The variants... marked with ★ exhibit visible mode-collapse... ESS is therefore not directly comparable") but does not discuss the trade-off between ESS and mode coverage more broadly, or what this implies about ESS as a metric.

### Trivial

- The ±0.00 standard error on several EUBO values (e.g., alanine tetrapeptide, alanine dipeptide) across 4 runs is suspiciously tight, though likely an artifact of metric saturation at high performance levels.
- The paper uses a fixed number of annealing steps \tilde{T} rather than the natural Lagrangian stopping criterion, but does not report the \tilde{T} values used.

## Nice-to-Haves

- **Report Lagrangian multiplier dynamics.** Showing λ_i and η_i across annealing steps for different systems would illustrate whether the combined constraint automatically adjusts the schedule as claimed.
- **Disentangle sources of improvement.** A controlled comparison with the same annealing schedule but different constraints (trust-region only, entropy only, both) already exists as the ablation, but a comparison that additionally varies the replay buffer or dual optimization scheme would isolate the contribution of each component.
- **Sweep over hyperparameters.** A study varying ε_tr and ε_ent across multiple system sizes would provide practical guidance for applying CMT to new problems.

## Removed Points

**Weakness #1 from Harsh Critic ("Unsupported quantitative claim in abstract") — partially removed and corrected.** The harsh critic claimed "The only comparison exceeding 2.5× is against forward KL." This is factually wrong: CMT achieves 26.06% ESS vs. FAB's 7.21% on the ELIL tetrapeptide = 3.61×, and FAB is explicitly identified as a SOTA baseline (line 236). The weakness is retained above but reframed accurately: the 2.5× claim is supported on one specific comparison (ELIL vs. FAB) but overstated as a general claim.

**Weakness #2 from Harsh Critic ("Gap between theoretical constraints and learned approximations") — demoted to Minor.** The paper is explicit that \hat{q}_i approximates q_i (Eq. 13, line 139: "despite having access to the analytical form of q_i, it is typically not possible to sample from it directly"). The constraints define the training target, not a hard constraint on the approximation—this is standard practice in variational methods. The criticism of not verifying constraint satisfaction on the approximation is reasonable as a nice-to-have but not a structural flaw.

**Criticism about the ±0.00 standard error — removed as trivial.** Saturated metrics often yield near-zero variance across runs, especially when the EUBO gap between methods is tiny (e.g., -334.00 vs -333.99). This is common in the literature and not a meaningful indicator of an error.

**Criticism about usefulness of Theorem 2.4 ("states the obvious") — removed.** The theorem formally establishes that the constrained optimization sequences correspond to specific annealing-path forms with monotonic β progressions, which is not "obvious" from the unconstrained Lagrangian solutions alone.

**Strength Finder claim about "directly substantiating the abstract's claim of >2.5×" on ELIL — kept but caveated.** The comparison is real but only applies vs. FAB, not TA-BG. This nuance is captured in the revised weakness above.

**All missing-appendix criticisms — removed per instructions.** The parser strips the appendix from all papers.

## Novel Insights

None beyond the paper's own contributions. The reviews surface no structural insight that the paper itself does not provide.

## Suggestions

1. **Revise the headline ESS claim.** Replace "more than 2.5× higher effective sample size" with a precise claim such as "up to 3.6× higher effective sample size (ELIL vs. FAB)" or "consistently 1.5–3.6× higher effective sample size across all benchmarks," and clarify in the main text which baselines this refers to.

2. **Add a sensitivity analysis for ε_tr and ε_ent** in the main paper (not just the appendix), either as a table or figure showing how performance varies with these bounds on different systems.

3. **Add a brief discussion of the RAM TV discrepancy on ELIL** and what it implies about the ESS vs. mode-coverage trade-off, perhaps noting that TA-BG's superior RAM TV comes with numerical instability (only 2 successful runs).

4. **Report the fixed \tilde{T} values** used for the annealing schedule and, if possible, compare with the natural stopping criterion (λ,η→0) to validate that \tilde{T} is large enough.

## Score and Decision

**Calibration anchors compared:**

| Paper | Avg Score | Comparison to this paper |
|-------|-----------|------------------------|
| GeoBFN (NSVtmmzeRB) | 8.00 | Strong molecular generation paper with clean theory and thorough experiments. Slightly stronger overall empirical validation. |
| BoPITO (pRCOZllZdT) | 7.00 | Also on Boltzmann generators, solid contribution but limited to small systems (1D, alanine dipeptide). This paper covers larger systems (d=60–219). |
| Fisher-Rao Curves (TUvg5uwdeG) | 6.40 | Related work on sampling from Boltzmann densities. Mainly 2D experiments; strong theory but limited practical impact. This paper has more practical benchmarks. |
| BNEM (ybWOYIuFl6) | 6.00 | Boltzmann sampler with variance analysis but experiments limited to GMM-40 and LJ systems (≤55 particles). This paper covers larger molecular systems. |
| Annealing Flow (XcAJ0qsMgh) | 3.60 | Similar scope (annealing + flows) but weak experiments, missing baselines, and theoretical issues. This paper is far stronger in all dimensions. |
| Fast RBM (3fGtV4Zfgq) | 4.25 | Mixed reviews, unclear novelty, limited experiments. This paper has clearer contributions and stronger validation. |
| Discovering Global Minima (OcTUquFXfx) | 2.60 | Very low-scoring; poorly received. This paper is orders of magnitude stronger. |

The paper provides a well-motivated theoretical framework, a strong ablation study, and competitive results on molecular benchmarks that are larger than those in prior energy-only Boltzmann generator work. The main weakness is the somewhat overstated "2.5×" claim. Compared to the calibration anchors, this paper sits between the 6.40 (Fisher-Rao) and 7.00 (BoPITO) level—better empirical validation than the former, comparable novelty to the latter but on larger systems. The paper is clearly not an 8.00 (high-scoring anchors have cleaner empirical validation and broader impact) but also clearly not below a 6.00.

MY FINAL SCORE: <score>6.5</score>
MY FINAL DECISION: <decision>Accept</decision>